Characterisation of recombinant 3CL protease from SARS-CoV-2 produced in E. coli BL21 (DE3) for screening anti-covid drug candidates using rhodamine 110-synthetic peptide conjugate as a substrate
The prediction that the pandemic is progressing towards becoming endemic does not change the fact that COVID-19 can still be fatal for individuals with weak immune systems. Therefore, anti-COVID drugs are still needed, even when the disease becomes endemic. With regards to SARS-CoV-2, the roles of 3...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2023
|
Online Access: | http://journalarticle.ukm.my/23353/1/SD%204.pdf |